Jacob Asset Management Of New York LLC Akouos, Inc. Transaction History

Jacob Asset Management Of New York LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$2.6 - $5.16 $36,920 - $73,272	14,200 Added 24.04%	73,273 $495,000
Q2 2022 Aug 11, 2022	SELL	$2.46 - $5.2 $2,460 - $5,200	-1,000 Reduced 1.66%	59,073 $277,000
Q1 2022 May 12, 2022	SELL	$4.16 - $9.08 $194,688 - $424,944	-46,800 Reduced 43.79%	60,073 $285,000
Q4 2021 Feb 09, 2022	BUY	$7.65 - $11.38 $236,178 - $351,334	30,873 Added 40.62%	106,873 $908,000
Q3 2021 Nov 12, 2021	SELL	$9.93 - $13.59 $188,670 - $258,210	-19,000 Reduced 20.0%	76,000 $882,000

Q1 2021 Oct 04, 2021	BUY	$13.87 - $21.04 $1.32 Million - $2 Million	95,000 New	95,000 $1.32 Million

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Jacob Asset Management Of New York LLC, based on Form 13F filings with the SEC.

Stay updated on Jacob Asset Management Of New York LLC with notifications on news.